Applied Nanotech and YHCC Sign Licensing Agreement for Solar Ink Technology

Applied Nanotech and Sichuan Anxian Yinhe Construction and Chemical Group (YHCC) have signed a licensing deal for the solar ink and paste technology.

The agreement provides an exclusive license to YHCC to commercialize Applied Nanotech's solar inks in Asia, except Japan and Korea. It is the first license agreement of Applied Nanotech with YHCC.

YHCC has started to build a manufacturing plant in China to produce solar inks and pastes. The first products that will be produced at the facility will be the aluminum pastes of Applied Nanotech. The production and sale of these pastes is anticipated to commence in 2012.

Applied Nanotech will have great exposure to the rapidly developing Asian solar market through this licensing deal. The partnership will result in the initial production of solar inks and both the companies are discussing on other alliance opportunities. Based on the agreement, Applied Nanotech will gain an upfront payment and continuing royalty on sales of solar pastes and inks from YHCC.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, February 09). Applied Nanotech and YHCC Sign Licensing Agreement for Solar Ink Technology. AZoM. Retrieved on September 23, 2024 from https://www.azom.com/news.aspx?newsID=29988.

  • MLA

    Chai, Cameron. "Applied Nanotech and YHCC Sign Licensing Agreement for Solar Ink Technology". AZoM. 23 September 2024. <https://www.azom.com/news.aspx?newsID=29988>.

  • Chicago

    Chai, Cameron. "Applied Nanotech and YHCC Sign Licensing Agreement for Solar Ink Technology". AZoM. https://www.azom.com/news.aspx?newsID=29988. (accessed September 23, 2024).

  • Harvard

    Chai, Cameron. 2019. Applied Nanotech and YHCC Sign Licensing Agreement for Solar Ink Technology. AZoM, viewed 23 September 2024, https://www.azom.com/news.aspx?newsID=29988.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.